Trials / Completed
CompletedNCT02659839
Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting
Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting: A Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 142 (actual)
- Sponsor
- Pontificia Universidad Catolica de Chile · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine 30 day mortality in cancer patients admitted to the intensive care unit in a resource limited setting.
Detailed description
The management of cancer patients in the intensive care unit (ICU) has changed dramatically during the last two decades. Initial experiences showed high rates of hospital mortality, reaching up to 75-85% in patients requiring life-sustaining treatments, particularly mechanical ventilation. An increasing number of clinical experiences has been reported pointing to a significant improvement in survival of these patients. However, it is not clear if this results are generalizable to settings with resource constraints. Therefore, the purpose of this study is to determine 30 day mortality in cancer patients admitted to the intensive care unit in a resource limited setting. This study is a prospective cohort of cancer patients admitted to the ICU in which the investigators will evaluate the prognostic of cancer patients admitted for a ICU trial or treatment in ICU without limitations. This study will not consider any change in the treatment plan of the patients. The source of the data will be the clinical records of the patients during the admission and the records of the cancer unit. There will be no direct contact of the research team with the patients or their family.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cancer patients admitted to the ICU | There will be no change in the standard ICU treatment. |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2016-01-20
- Last updated
- 2016-10-27
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT02659839. Inclusion in this directory is not an endorsement.